Adjuvant radiotherapy after extrapleural pneumonectomy for mesothelioma. Prospective analysis of a multi-institutional series

Radiotherapy and Oncology

Volumn 101, Issue 2, 2011, Pages 311-315

  Tonoli, Sandro ^a   Vitali, Paola ^a   Scotti, Vieri ^b   Bertoni, Filippo ^c   Spiazzi, Luigi ^d   Ghedi, Barbara ^d   Buonamici, Fabrizio Banci ^b,g   Marrazzo, Livia ^b   Guidi, Gabriele ^c   Meattini, Icro ^b   Bastiani, Paolo ^e   Amichetti, Maurizio ^f   Schwarz, Marco ^f   Magrini, Stefano Maria ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c Modena Hospital   (Italy)

^d SPEDALI CIVILI   (Italy)

^e SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^f UNIVERSITY OF TRENTO   (Italy)

^g Siena University Hospital   (Italy)

Author keywords

Extrapleural pneumonectomy; IMRT; Malignant pleural mesothelioma; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER FATIGUE; CANCER SURVIVAL; COUGHING; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DYSPHAGIA; DYSPNEA; ESOPHAGITIS; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; KIDNEY PERFUSION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MULTICENTER STUDY; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INDUCED EMESIS; RADIATION SICKNESS; SURVIVAL RATE; TOMOTHERAPY;

ADULT; AGED; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; ITALY; KIDNEY; LIVER; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 81755165761     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.09.025     Document Type: Article

References (19)

1. A. Marinaccio, M. Nestia Regional Operational Centers Analyses of survival of mesothelioma cases in the Italian register (ReNaM) Eur J Cancer 39 2003 1290 1295 (Pubitemid 36579202)
2. F. Montanaro, R. Rosato, and M. Gangemi Survival of pleural malignant mesothelioma in Italy: a population-based study Int J Cancer 124 2009 201 207
3. A. Ahamed, C.W. Stevens, and W.R. Smythe Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma Int J Radiat Oncol Biol Phys 55 2003 768 775 (Pubitemid 36170016)
4. R.M. Flores, I.P. Harvey, and V.E. Seshan Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients J Thorac Cardiovasc Surg 135 2008 620 627
5. C. Pinto, A. Ardizzoni, and P.G. Betta Expert Opinions of the First Italian Consensus Conference on the management of malignant pleural mesothelioma Am J Clin Oncol 34 2011 99 109
6. A. Scherpereel French Speaking Society for Chest Medicine (SPLF) Experts Group Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma Respir Med 101 2007 1265 1276 (Pubitemid 46671140)
7. E.H. Baldini, A. Rech, and G.M. Strass Patterns of failure after trimodality therapy for malignant mesothelioma Ann Thorac Surg 63 1997 334 338 (Pubitemid 27084548)
8. T.D. Yan, M. Boyer, and M.M. Tin Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors J Thorac Cardiovas Surg 138 2009 619 624
9. T. Treasure, D. Waller, and C. Tan The mesothelioma and radical surgery randomized controlled trial: the MARS Feasibility Study J Thorac Oncol 4 2009 1254 1258
10. M.A. Allen, M. Czerminska, and P.A. Jänne Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma Int J Radiat Oncol Biol Phys 65 2006 640 645 (Pubitemid 43795851)
11. C.A. Kristensen, T.J. Nøttrup, and A.K. Berthelsenet Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma Radiother Oncol 92 2009 96 99
12. J.P. Van Mererbeeck, A. Scherpereel, V.F. Surmont, and P. Baas Malignant pleural mesothelioma: the standard of care and challenges for future management Crit Rev Oncol Hematol 78 2011 92 111
13. D.J. Sugarbaker, R.M. Flores, and M.T. Jaklitsch Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy for malignant pleural mesothelioma: results in 183 patients J Thorac Cardiovasc Surg 117 1999 54 63
14. D.C. Rice, C.W. Stevens, and A.M. Correa Outcomes after extrapleural pneumonectomy and intensity modulated radiation therapy for malignant mesothelioma Ann Thorac Surg 84 2007 1685 1692
15. British Thoracic Society Standards of Care Committee. BTS statement on malignant mesothelioma in the UK, 2007. Thorax 2007;62:ii1-19.
16. R.A. Stahel, W. Weder, E. Felip ESMO Guidelines Working Group Malignant pleural mesothelioma: ESMO clinical recommendations for diagnosis, treatment and follow-up Ann Oncol 19 2008 43 44
17. NCCN Mesothelioma Panel Members, NCCN clinical practice guidelines in oncology. V. 1 2010. Accessed at http://www.nccn.org.
18. Lorentini S, Hammer P, Amichetti M, Spiazzi L, Tonoli S, Magrini SM, et al. Intensity Modulated Proton Therapy (IMPRT) vs. Intensity Modulated Radiation Therapy (IMRT) in malignant pleural Mesothelioma: a dosimetric comparison. Accessed at: http://www.aifm2009.org.
19. Guidi G, Amadori M, Antognoni P, et al. Multicenter intercomparison for treatment of the mesothelioma with IMRT and tomotherapy. Accessed at: http://www.aifm2009.org.